Viewing Study NCT04364035


Ignite Creation Date: 2025-12-24 @ 10:08 PM
Ignite Modification Date: 2025-12-25 @ 7:44 PM
Study NCT ID: NCT04364035
Status: COMPLETED
Last Update Posted: 2023-07-27
First Post: 2020-03-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety, Tolerability and Immunogenicity of MVA.HTI and ChAdOx1.HTI With Vesatolimod in HIV-1 Positive Patients
Sponsor: Aelix Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module